Correlation Between ABVC Biopharma and Akari Therapeutics
Can any of the company-specific risk be diversified away by investing in both ABVC Biopharma and Akari Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ABVC Biopharma and Akari Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ABVC Biopharma and Akari Therapeutics PLC, you can compare the effects of market volatilities on ABVC Biopharma and Akari Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ABVC Biopharma with a short position of Akari Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ABVC Biopharma and Akari Therapeutics.
Diversification Opportunities for ABVC Biopharma and Akari Therapeutics
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between ABVC and Akari is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding ABVC Biopharma and Akari Therapeutics PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Akari Therapeutics PLC and ABVC Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ABVC Biopharma are associated (or correlated) with Akari Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Akari Therapeutics PLC has no effect on the direction of ABVC Biopharma i.e., ABVC Biopharma and Akari Therapeutics go up and down completely randomly.
Pair Corralation between ABVC Biopharma and Akari Therapeutics
Given the investment horizon of 90 days ABVC Biopharma is expected to under-perform the Akari Therapeutics. But the stock apears to be less risky and, when comparing its historical volatility, ABVC Biopharma is 1.49 times less risky than Akari Therapeutics. The stock trades about -0.28 of its potential returns per unit of risk. The Akari Therapeutics PLC is currently generating about -0.15 of returns per unit of risk over similar time horizon. If you would invest 138.00 in Akari Therapeutics PLC on November 5, 2024 and sell it today you would lose (29.00) from holding Akari Therapeutics PLC or give up 21.01% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
ABVC Biopharma vs. Akari Therapeutics PLC
Performance |
| Timeline |
| ABVC Biopharma |
| Akari Therapeutics PLC |
ABVC Biopharma and Akari Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ABVC Biopharma and Akari Therapeutics
The main advantage of trading using opposite ABVC Biopharma and Akari Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ABVC Biopharma position performs unexpectedly, Akari Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Akari Therapeutics will offset losses from the drop in Akari Therapeutics' long position.| ABVC Biopharma vs. Indaptus Therapeutics | ABVC Biopharma vs. Pasithea Therapeutics Corp | ABVC Biopharma vs. Forte Biosciences | ABVC Biopharma vs. Akari Therapeutics PLC |
| Akari Therapeutics vs. Armata Pharmaceuticals | Akari Therapeutics vs. Anebulo Pharmaceuticals | Akari Therapeutics vs. Processa Pharmaceuticals | Akari Therapeutics vs. Salarius Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world |